DMEMEDS shared post via Reuters: Qiagen wins U.S. approval for test to accompany Amgen cancer drug

FRANKFURT (Reuters) - U.S. health regulators on Friday approved Qiagen NV's gene-testing kit to identify those colorectal cancer patients most likely to benefit from Amgen Inc's drug, Vectibix, Qiagen said. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/qLj-zpAuZok/story01.htm

Read More